|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue (including related party costs of $177,076, $231,803 and $302,910 for the years ended December 31, 2023, 2024 and 2025, respectively) | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating profit (loss) | |||||
| Financial expenses (income), net | |||||
| Profit (loss) before income taxes | |||||
| Provision for income taxes (benefits) | |||||
| Net Income (loss) | |||||
| Net Income (loss) attributable to ordinary shareholders | |||||
| Net Income (loss) per share attributable to ordinary shareholders, basic | |||||
| Net Income (loss) per share attributable to ordinary shareholders, diluted | |||||
| Weighted-average shares used in computing net income (loss) per share attributable to ordinary shareholders, basic | |||||
| Weighted-average shares used in computing net income (loss) per share attributable to ordinary shareholders, diluted | |||||
Loading...
